A podcast and long read series exploring new research into the brain and dementia.
Academic rigour, journalistic flair
Articles on Alzheimer's disease
Displaying 81 - 100 of 351 articles
Too much amyloid-beta in the brain has long been considered the cause of Alzheimer’s. New research suggests it might be the opposite.
Lecanemab, an experimental dementia drug, slowed cognitive decline by 27% in late-stage clinical trials.
Here’s why it’s so important to look after your oral health.
New study finds that middle-aged people who had nightmares every week, are four times more likely to experience cognitive decline.
Action is needed to hold off a wave of dementia cases in an aging population. One of the most effective tools to reduce the prevalence of dementia is to address modifiable factors.
Alzheimer’s may not be primarily a disease of the brain. It may be a disorder of the immune system within the brain. Beta-amyloid may not be an abnormal protein, but part of the brain’s immune system.
A thinning of the retina is associated with earlier ageing of the brain. Widely available retinal imaging could help detect cognitive decline in its earliest stages.
Nonhuman primates like rhesus monkeys share certain characteristics with people that may make them better study subjects than mice for research on neurodegenerative diseases.
You may dismiss many behaviour changes as just a normal part of ageing. But it may be doggy dementia, or canine cognitive dysfunction.
Diets high in fat, sugar and processed foods are associated with higher calorie intake, poorer memory and lower cognitive function.
A highly cited paper on Alzheimer’s disease may have been purposely manipulated.
From thalidomide to resveratrol, molecules with the exact same chemical properties can have drastically different effects in the body depending on how they’re arranged in space.
Not all Alzheimer’s research has been compromised by allegations of scientific fraud. But we should interrogate whether the governing bodies of research and drug approvals are truly effective.
Much dementia research does not reflect ethnically diverse communities. Studies used to make policy, clinical and investment decisions in dementia should reflect the diverse Canadian population.
Noradrenergic drugs are already used to treat a variety of conditions, including ADHD and depression.
Because they help to create a shared understanding, metaphors can play a critical role in navigating the gap between the knowledge patients and health-care providers bring.
Participants who woke up fewer times during the night performed better on memory tasks the next day.
Cell cultures have shown promise in representing diseases. The Petri dish is not as different from a sick person as one might think.
Long overlooked by scientists, white matter may provide clues to some of the brain’s greatest mysteries.
Top contributors
-
Research Fellow in Neuroimmunology, UCL
-
Associate Professor, Turner Institute for Brain and Mental Health, Monash University
-
Professor of Neurology and Neuroscience, University of Florida
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Professor of Neurology, UCL
-
Professor of Psychology in Epidemiology, UCL
-
Post grad student at University of Edinburgh, The University of Edinburgh
-
Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Investigations Editor, Insights, The Conversation
-
Associate Professor of Medicine and Geriatrics, University of Virginia
-
Editor and Co-Host, The Conversation Weekly Podcast, The Conversation
-
Postdoctoral Research Fellow, Tufts University
